Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

FDA clears new left-heart access system from Atraverse Medical
The Hotwire Transseptal Access System includes the Hotwire RF Generator and Hotwire RF Guidewire, giving electrophysiologists the tools they need for left-heart access.
$V-Wave has gained considerable attention or its Ventura Interatrial Shunt System, a small implantable device designed to reduce pressure on the left atrium and the lungs in patients with heart failure with reduced ejection fraction (HFrEF). The Ventura device includes a nitinol hourglass-shaped frame that anchors to the patient’s fossa ovalis in a way that prevents migration or embolization. It is implanted via an interventional procedure with fluoroscopy and echocardiography guidance.$
FDA panel votes against approving first-of-its-kind heart failure device
All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.
Drug discounts for safety-net hospitals up in the air and into the courts
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time.
FDA issues warning about Olympus ligating devices after 113 injuries
The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.

Health companies launch FDA-approved blockchain pilot

A pilot that aims to study the use of blockchain-enabled data technology to track and verify specialty prescription drugs has been approved by the FDA.

Guidelines updated for radiation therapy after prostatectomy

The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have updated their clinical guidelines for adjuvant and salvage radiotherapy following prostatectomy.

Interventional radiology societies recommend PAE for men with enlarged prostates

Prostatic artery embolization (PAE) is an effective, minimally invasive treatment option for men with enlarged prostates, according to a new position statement from four interventional radiology societies.

Following Aetna integration, CVS earnings soar 35% in first quarter report

CVS Health, fresh off a $69 billion takeover of health insurance giant Aetna, saw its revenues increase 34.8% to $61.6 billion during the first quarter of 2019, according to a May 1st earnings report. In addition, net income rose 43%, to $1.4 billion, from the previous year.

SWE could help assess suspicious findings detected on mammograms

Shear wave elastography (SWE) may be an effective tool for characterizing suspicious microcalcifications of the breast first detected on mammograms, according to a new study published in the American Journal of Roentgenology.

Interventional radiology societies endorse prostatic artery embolization for certain patients

The Society of Interventional Radiology (SIR) and numerous other societies have endorsed prostatic artery embolization (PEA) as a safe and effective method to treat an enlarged prostate in certain patients.

U.N. warns the world to fight superbugs now or pay dearly later

As bacterial germs continue to mutate and proliferate due to the overuse of antibiotics, an arm of the United Nations is laying out the disturbing numbers in hopes of stirring people to action all around the world.

CMS takes steps to beef up oversight of accrediting organizations

CMS has proposed a new rule that aims to improve transparency around accrediting organizations (AOs) that certify healthcare facilities in the Medicare program. Specifically, the rule creates a new process for AOs to follow if there is a sale, transfer or purchase of assets in the ownership of the organization.

Management

FDA clears new left-heart access system from Atraverse Medical

FDA panel votes against approving first-of-its-kind heart failure device

Drug discounts for safety-net hospitals up in the air and into the courts

FDA issues warning about Olympus ligating devices after 113 injuries

Patient communication AI company receives $65M in funding from private equity